Skip to main content
OpenTrials

Clinical trial condition

Peritoneal Diseases

Explore clinical trials studying Peritoneal Diseases. Study availability and eligibility vary by location and protocol.

373 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Peritoneal Diseases trial results

Active, Not Recruiting

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

NCT04498117

Conditions
Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
Locations
  • Honor Health Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • John Muir Health Clinical Research Center Concord, California, United States
  • Kaiser Permanente Southern California Irvine, California, United States
View all 148 locations
View Trial Details
Active, Not Recruiting

Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

NCT02758951

Conditions
Abdominal Neoplasms, Body Temperature Changes, Colonic Diseases, +28 more
Locations
  • Ziekenhuis Oost-Limburg Genk, Flanders, Belgium
  • Amsterdam University Medical Centre, Location VUMC Amsterdam, Netherlands
  • Netherlands Cancer Institute Amsterdam, Netherlands
  • Catharina Hospital Eindhoven, Netherlands
View Trial Details
Active, Not Recruiting

Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors

NCT03252938

Conditions
Abdominal Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +12 more
Locations
  • Helios Klinikum Bad Saarow Bad Saarow, Germany
  • Kliniken der Stadt Köln gGmbH, Studienzentrum der Lungenklinik, Krankenhaus Merheim Cologne, Germany
  • Universitätsklinikum Essen Essen, Germany
  • Agaplesion Markus Krankenhaus Frankfurter Diakonie Kliniken gGmbH Frankfurt, Germany
View Trial Details
Active, Not Recruiting

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

NCT05617755

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adnexal Diseases, +29 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • U of Colorado Cancer Center - Anschutz Medical Campus Aurora, Colorado, United States
  • U of Iowa Health Care Iowa City, Iowa, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer

NCT02571725

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +21 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Southwest Gynecologic Oncology Associates Albuquerque, New Mexico, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details

Related conditions